Patient info Open main menu

Fortum 1 g powder for solution for injection or infusion – patient leaflet, side effects, dosage

Medicine status: No longer supplied Details

Medicine strength:
1 g
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Other strengths and forms:
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Fortum 1 g powder for solution for injection or infusion

Sources: Original (products.mhra.gov.uk)

Facts about Fortum 1 g powder for solution for injection or infusion

Active substance Ceftazidime
Strength 1 g
Pharmaceutical form Powder for solution for injection
Vials containing white to cream sterile powder.
How is it taken Intravenous, Intramuscular
Excipients Sodium carbonate (anhydrous sterile)
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
After reconstitution:
Chemical and physical in-use stability has been demonstrated for 6 days at 4°C and 9 hours at 25°C.
From a microbiological point of view, the reconstituted solution should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions.
After dilution:
Chemical and physical in-use stability has been demonstrated for 6 days at 4°C and 9 hours at 25°C.
From a microbiological point of view, the reconstituted and diluted solution should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions.
Storage Store below 25°C.
Keep vials in the outer carton to protect from light.
For storage conditions after reconstitution see section 6.3.
Drug group (ATC) Antibacterials for systemic use
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DD Third-generation cephalosporins
          1. J01DD02 ceftazidime
Marketing authorisation PL 48870/0035 (first authorised 17 October 1983)
Marketing authorisation holder Sandoz Pharmaceuticals d.d.
Codes BNF 05010201

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.